Can the use of bone marrow parameters improve the efficacy of risk prediction scores in chronic myeloid leukemia in imatinib era??

Development of various risk scores for chronic myeloid leukemia prognostication and intensification of treatment accordingly has been an area of research. Our data confirms that by using bone marrow parameters instead of conventional peripheral blood parameters we could improve efficacy of Sokal and EUTOS risk scores.

Source: Clinical Lymphoma, Myeloma and Leukemia - March 29, 2017 Category: Hematology Authors: Govind Babu Kanakasetty, Aditi Harsh Thanky, Lakshmaiah Kuntegowdanahalli, Lokanatha Dasappa, Linu Jacob, Suresh Babu Mallekavu, Rajeev Lakkavalli, Lokesh Kadabur, Rudresha Antapura Tags: Original Study Source Type: research